NCT06209515

Brief Summary

In this retrospective register study, clinically classified individuals with neurodegenerative disease from the years 2010-2021 will be verified from the clinical records from KUH and Oulu University Hospital (OUH). Based on the Finnish social security number, these individuals will be linked to the the national registers of Statistics Finland and Finnish Social and Health Data Permit Authority Findata including incomes, sociodemographic factors, education, occupation, criminal records as well as to the national registers including the bought pharmaceuticals, comorbidities and causes of death. For each study case, 10 randomly selected control cases, matched with age, sex and geographical area, will be used. The aim of the study is to examine:

  • 1\) The prevalence of criminal and other disruptive behaviour in groups of different neurodegenerative diseases prior to and after the diagnosis
  • 2\) Changes in employment, residency,income, and marital status prior to and after the neurodegenerative disease diagnosis
  • 3\) Hospital diagnoses and reimbursable drugs prior to and after the diagnosis
  • 4\) Causes of death in patients with neurodegenerative disease to study excess mortality of the patients

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61,292

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Jan 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Jan 2022Dec 2027

Study Start

First participant enrolled

January 1, 2022

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

January 8, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 17, 2024

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

January 31, 2024

Status Verified

January 1, 2024

Enrollment Period

6 years

First QC Date

January 8, 2024

Last Update Submit

January 29, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Criminal behaviour: Type of offence, time of offence and other disruptive behaviour

    Statistics Finland, Statistics on offences and coercive measures. Criminal behaviour is investigated utilising the reports of offences received by the police. The classification of offences is based on the three- or six-numbered offence classification by Statistics Finland, which enables the examination of different offences including e.g., violence, property, and traffic offences. The data extracted from the register include the type of the offence and time. Also, other disruptive behaviour based on the captures performed by the police (e.g., captures of intoxicated persons) is extracted.

    1996-2020

  • Socio-demographic data

    Employment, residency, Income, Marital status. Socio-demographic outcome data is extracted from Statistics Finland, FOLK Basic data module. Possible changes in employment and residency are examined, and mortality and emigration will be considered as censoring factors

    1987-2021

  • Hospital diagnoses

    Hospital diagnoses from the National Discharge Register. The National Discharge Register contains information of all hospitalizations after 1969, including ICD-8, ICD-9, and ICD-10 classifications to detect comorbidities of the patients. Two registers, "Terveydenhuollon hoitoilmoitusrekisteri (Hilmo)" and "Perusterveydenhuollon avohoidon hoitoilmoitus (Avohilmo)" of the Finnish Institute for Health and Welfare are used.

    1994-2021

  • Medication use

    Reimbursable drugs from the Social Insurance Institution of Finland (SII). Finnish residents are covered under the National Health Insurance (NHI) scheme run by the SII. SII maintains a nationwide registry of all patients, with dispensed reimbursable drugs 1995-, including opioids and neuropathic pain medications. Data of medication use, cost, and reimbursement data are gathered from the SII database.

    1995-2021

  • Causes of death

    Causes of death from Statistics Finland. Statistics Finland maintains a registry of causes of death and death certificates, which are supplemented with data from the population information system of the Population Register Centre. Registry data are used to study excess mortality of the patients.

    2010-2021

Study Arms (2)

Patients with neurodegenerative disease

Patient diagnosed with neurodegenerative disease (ICD-10 diagnosis code) between 2010-2021

Matched controls

Age, gender, and place of residency matched for those of a patient that was alive at the end of the year of the diagnosis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All consecutive patients admitted to Kuopio University Hospital (KUH) and Oulu University Hospital (OUH) Neurology outpatient clinic with a progressive neurodegenerative disease during 2010-2021 are identified from KUH and OUH data registry with all ICD-10 codes used in the diagnostics of neurodegenerative diseases. Their estimated number is 5572 patients. Clinical data of these patients are retrieved from the corresponding hospital data lakes. The patients will be divided into different diagnostic groups based on the accepted diagnostic criteria in use. Further, a matched control cohort is retrieved from the Finnish Population Information System maintained by the Digital and Population Data Services Agency. Every research patient has 10 controls matched by age, gender, and place of residency (according to the year of diagnosis), and the matching is performed for research patients that were alive at the end of the year of the diagnosis.

You may qualify if:

  • The diagnosis of neurodegenerative disease (ICD-10) in KUH or OUH between the years 2010-2021
  • Age, sex and residency matched controls (Every research patient has 10 controls matched by age, gender, and place of residency)

You may not qualify if:

  • Patients will be divided into different diagnostic groups based on the accepted diagnostic criteria in use. If some of the formed groups contain less than 5 subjects, the disease group in question is excluded from the analyses in order to ensure the privacy protection of the subjects

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kuopio University Hospital

Kuopio, Finland

Location

MeSH Terms

Conditions

Neurodegenerative DiseasesAlzheimer DiseaseFrontotemporal DementiaLewy Body DiseaseDementia, VascularParkinson DiseaseSupranuclear Palsy, ProgressiveCorticobasal DegenerationMultiple System AtrophyAmyotrophic Lateral SclerosisHuntington Disease

Condition Hierarchy (Ancestors)

Nervous System DiseasesDementiaBrain DiseasesCentral Nervous System DiseasesTauopathiesNeurocognitive DisordersMental DisordersFrontotemporal Lobar DegenerationTDP-43 ProteinopathiesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic DiseasesParkinsonian DisordersBasal Ganglia DiseasesMovement DisordersSynucleinopathiesCerebrovascular DisordersIntracranial ArteriosclerosisIntracranial Arterial DiseasesLeukoencephalopathiesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesOphthalmoplegiaOcular Motility DisordersCranial Nerve DiseasesParalysisNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPrimary DysautonomiasAutonomic Nervous System DiseasesSpinal Cord DiseasesMotor Neuron DiseaseNeuromuscular DiseasesChoreaDyskinesiasHeredodegenerative Disorders, Nervous SystemGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCognition Disorders

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2024

First Posted

January 17, 2024

Study Start

January 1, 2022

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

January 31, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations